Lipocalin-2, Soluble Transferrin Receptor, and Erythropoietin in Anemia During Mild Renal Dysfunction

References

• Leoncini G, Viazzi F, Parodi D, et al. Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. Hypertension. 2003;42(1):14–18. doi:10.1161/01.HYP.0000075789.58883.73
   PubMed Web of Science ®Google Scholar
• Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int. 1999;56(6):2214–2219.
   PubMed Web of Science ®Google Scholar
• Cases A, Coll E. Dyslipidemia and the progression of renal disease in chronic renal failure patients. Kidney Int. 2005;68(Suppl 99):S87–S93.
   Google Scholar
• Andrade-Oliveira V, Foresto-Neto O, Watanabe IKM, Zatz R, Câmara NOS. Inflammation in renal diseases: new and old players. Front Pharmacol. 2019;10:1192.
   PubMed Web of Science ®Google Scholar
• Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med. 2002;162(12):1401–1408.
   PubMed Web of Science ®Google Scholar
• Herzog CA, Muster HA, Li S, Collins AJ. Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. J Card Fail. 2004;10(6):467–472.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang L, Dey S, et al. Erythropoietin action in stress response, tissue maintenance and metabolism. Int J Mol Sci. 2014;15(6):10296–10333.
   PubMed Web of Science ®Google Scholar
• Chang CC, Kass L. Clinical significance of immature reticulocyte fraction determined by automated reticulocyte counting. Am J Clin Pathol. 1997;108(1):69–73.
   PubMed Web of Science ®Google Scholar
• Jaberi SA, Cohen A, D’Souza C, et al. Lipocalin-2: structure, function, distribution and role in metabolic disorders. Biomed Pharmacother. 2021;142:112002.
   PubMed Web of Science ®Google Scholar
• Devarajan P. Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med. 2010;4(2):265–280. doi:10.2217/bmm.10.12
   PubMed Web of Science ®Google Scholar
• Lim D, Jeong J-H, Song J, Devarajan P. Lipocalin 2 regulates iron homeostasis, neuroinflammation, and insulin resistance in the brains of patients with dementia: evidence from the current literature. CNS Neurosci Ther. 2021;27(8):883–894. doi:10.1111/cns.13653
   PubMed Web of Science ®Google Scholar
• Miharada K, Hiroyama T, Sudo K, Danjo I, Nagasawa T, Nakamura Y. Lipocalin 2-mediated growth suppression is evident in human erythroid and monocyte/macrophage lineage cells. J Cell Physiol. 2008;215(2):526–537.
   PubMed Web of Science ®Google Scholar
• Gupta S, Uppal B, Pawar B. Is soluble transferrin receptor a good marker of iron deficiency anemia in chronic kidney disease patients? Indian J Nephrol. 2009;19(3):96–100.
   PubMedGoogle Scholar
• Chua E, Clague JE, Sharma AK, Horan MA, Lombard M. Serum transferrin receptor assay in iron deficiency anaemia and anaemia of chronic disease in the elderly. QJM. 1999;92(10):587–594.
   PubMedGoogle Scholar
• Oustamanolakis P, Koutroubakis IE, Messaritakis I, Niniraki M, Kouroumalis EA. Soluble transferrin receptor-ferritin index in the evaluation of anemia in inflammatory bowel disease: a case-control study. Ann Gastroenterol. 2011;24(2):108–114.
   PubMedGoogle Scholar
• Derchi LE, Leoncini G, Parodi D, et al. Mild renal dysfunction and renal vascular resistance in primary hypertension. Am J Hypertens. 2005;18(7):966–971.
   PubMed Web of Science ®Google Scholar
• Choi JW, Lee MH, Fujii T. Relationship between neutrophil gelatinase-associated lipocalin, eosinophil cationic protein, cytokines, and atopic sensitization in patients with allergic diseases. Biomed Res Int. 2022;2022:6564706.
   PubMed Web of Science ®Google Scholar
• Choi JW, Pai SH. Reticulocyte subpopulations and reticulocyte maturity index (RMI) rise as body iron status falls. Am J Hematol. 2001;67(2):130–135.
   PubMed Web of Science ®Google Scholar
• Choi JW, Fujii T. The prevalence of low plasma neutrophil gelatinase-associated lipocalin level in systemic inflammation and its relationship with proinflammatory cytokines, procalcitonin, nutritional status, and leukocyte profiles. Clin Lab. 2019;65(6):1063–1074.
   Web of Science ®Google Scholar
• Craig KJ, Williams JD, Riley SG, et al. Anemia and diabetes in the absence of nephropathy. Diabetes Care. 2005;28(5):1118–1123.
   PubMed Web of Science ®Google Scholar
• Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol. 2010;5(6):1003–1009.
   PubMed Web of Science ®Google Scholar
• Erman A, Rahamimov R, Mashraki T, et al. The urine albumin-to-creatinine ratio: assessment of its performance in the renal transplant recipient population. Clin J Am Soc Nephrol. 2011;6(4):892–897.
   PubMed Web of Science ®Google Scholar
• Kim SS, Song SH, Kim IJ, et al. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients. Diabetes Res Clin Pract. 2012;97(2):251–257.
   PubMed Web of Science ®Google Scholar
• Choi JW, Fujii T, Fujii N. Corrected neutrophil gelatinase-associated lipocalin (NGAL) level adjusted by the scoring system of an inflammation index for screening renal dysfunction in patients with systemic inflammation. Ann Clin Lab Sci. 2015;45(3):248–255.
   PubMed Web of Science ®Google Scholar
• Choi JW, Lee MH, Fujii T. Usefulness of the neutrophil gelatinase-associated lipocalin/inflammation index ratio for assessing diabetic nephropathy in patients with type 2 diabetes. Int J Clin Exp Med. 2021;14(9):2315–2324.
   Web of Science ®Google Scholar
• Lee JH, Yim HE, Yoo KH. Associations of plasma neutrophil gelatinase-associated lipocalin, anemia, and renal scarring in children with febrile urinary tract infections. J Korean Med Sci. 2020;35(10):e65.
   PubMed Web of Science ®Google Scholar
• Shrestha K, Borowski AG, Troughton RW, Klein AL, Tang WH. Association between systemic neutrophil gelatinase-associated lipocalin and anemia, relative hypochromia, and inflammation in chronic systolic heart failure. Congest Heart Fail. 2012;18(5):239–244.
   PubMedGoogle Scholar
• Krzemien GJ, Pańczyk-Tomaszewska M, Turczyn A, Demkow U, Kotuła I, Szmigielska A. Serum neutrophil gelatinase-associated lipocalin for predicting anemia of inflammation in children with urinary tract infection. Cent Eur J Immunol. 2021;46(4):456–462.
   PubMed Web of Science ®Google Scholar
• Wu X, Mao Y, Zhang Y, Hong Z, Zhu M. Study the role of neutrophil gelatinase-associated lipocalin on rat renal anemia. Int J Clin Exp Med. 2020;13(3):1720–1727.
   Web of Science ®Google Scholar
• Patsaoura A, Tatsi E, Margeli A, et al. Plasma neutrophil gelatinase-associated lipocalin levels are markedly increased in patients with non-transfusion-dependent thalassemia: lack of association with markers of erythropoiesis, iron metabolism and renal function. Clin Biochem. 2014;47(12):1060–1064.
   PubMed Web of Science ®Google Scholar
• Lindberg S, Jensen JS, Mogelvang R, et al. Plasma neutrophil gelatinase-associated lipocalinin in the general population: association with inflammation and prognosis. Arterioscler Thromb Vasc Biol. 2014;34(9):2135–2142.
   PubMed Web of Science ®Google Scholar
• Otto GP, Hurtado-Oliveros J, Chung HY, et al. Plasma neutrophil gelatinase-associated lipocalin is primarily related to inflammation during sepsis: a translational approach. PLoS One. 2015;10(4):e0124429.
   PubMed Web of Science ®Google Scholar
• Davis BH, Ornvold K, Bigelow NC. Flow cytometric reticulocyte maturity index: a useful laboratory parameter of erythropoietic activity in anemia. Cytometry. 1995;22(1):35–39.
   PubMedGoogle Scholar
• Davis BH, Bigelow N, Ball ED, Mills L, Cornwell GG. Utility of flow cytometric reticulocyte quantification as a predictor of engraftment in autologous bone marrow transplantation. Am J Hematol. 1989;32(2):81–87.
   PubMed Web of Science ®Google Scholar
• Bolignano D, Coppolino G, Donato V, Lacquaniti A, Bono C, Buemi M. Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? Med Sci Monit. 2010;16(6):RA131–RA135.
   PubMed Web of Science ®Google Scholar
• Miharada K, Hiroyama T, Sudo K, Nagasawa T, Nakamura Y. Lipocalin 2 functions as a negative regulator of red blood cell production in an autocrine fashion. FASEB J. 2005;19(13):1881–1883.
   PubMedGoogle Scholar
• Elliott S, Pham E, Macdougall IC. Erythropoietin: a common mechanism of action. Exp Hematol. 2008;36(12):1573–1584.
   PubMed Web of Science ®Google Scholar
• Fehr T, Ammann P, Garzoni D, et al. Interpretation of erythropoietin levels in patients with various degrees of renal insufficiency and anemia. Kidney Int. 2004;66(3):1206–1211.
   PubMed Web of Science ®Google Scholar
• Korte W, Cogliatti SB, Jung K, Riesen W. Mild renal dysfunction is sufficient to induce erythropoietin deficiency in patients with unexplained anemia. Clin Chim Acta. 2000;292(1–2):149–154.
   PubMed Web of Science ®Google Scholar
• Ble A, Fink JC, Woodman RC, et al. Renal function, erythropoietin, and anemia of older persons: the InCHIANTI study. Arch Intern Med. 2005;165(19):2222–2227.
   PubMedGoogle Scholar
• Jiang W, Constante M, Santos MM. Anemia upregulates lipocalin 2 in the liver and serum. Blood Cells Mol Dis. 2008;41(2):169–174.
   PubMed Web of Science ®Google Scholar
• Yazdani M, Merrikhi A, Beni ZN, Baradaran A, Soleimani N, Musazade H. Association between neutrophil gelatinase-associated lipocalin and iron deficiency anemia in children on chronic dialysis. J Res Med Sci. 2014;19(7):624–628.
   PubMed Web of Science ®Google Scholar
• Bolignano D, Coppolino G, Romeo A, et al. Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in hemodialysis patients. Nephrol Dial Transplant. 2009;24(11):3398–3403.
   PubMed Web of Science ®Google Scholar
• Emans ME, Braam B, Diepenbroek A, et al. Neutrophil gelatinase-associated lipocalin (NGAL) in chronic cardiorenal failure is correlated with endogenous erythropoietin levels and decreases in response to low-dose erythropoietin treatment. Kidney Blood Press Res. 2012;36(1):344–354.
   PubMed Web of Science ®Google Scholar
• Braga F, Infusino I, Dolci A, Panteghini M. Soluble transferrin receptor in complicated anemia. Clin Chim Acta. 2014;431:143–147.
   PubMed Web of Science ®Google Scholar